AYOME

Wardwizard Healthcare Share Price

 

 

Start SIP in AYOME

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 3 Month + 15.69%
  • Over 6 Month + 62.63%
  • Over 1 Year + 139.89%

Smart Investing Starts Here Start SIP with Wardwizard Healthcare for Steady Growth!

Invest Now

Wardwizard Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Wardwizard Healthcare Financials

Wardwizard Healthcare Technicals

EMA & SMA

Current Price
₹45.34
0 (0%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹29.71
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

45.34 Pivot Speed
  • R3 45.34
  • R2 45.34
  • R1 45.34
  • S1 45.34
  • S2 45.34
  • S3 45.34

Wardwizard Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-14 Quarterly Results
2025-10-28 Others Inter-alia, to consider 1. Appointment of Company Secretary and Compliance Officer of the Company. 2. Change the Key Managerial Personnel pursuant to Regulation 30(5). 3. Other business matters.
2025-08-11 Quarterly Results
2025-05-27 Audited Results

Wardwizard Healthcare F&O

Wardwizard Healthcare Shareholding Pattern

No data available.

Wardwizard Healthcare FAQs

Wardwizard Healthcare share price is ₹45 As on 12 February, 2026 | 04:33

The Market Cap of Wardwizard Healthcare is ₹1.1 Cr As on 12 February, 2026 | 04:33

The P/E ratio of Wardwizard Healthcare is -0.5 As on 12 February, 2026 | 04:33

The PB ratio of Wardwizard Healthcare is -0.3 As on 12 February, 2026 | 04:33

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23